trapidil has been researched along with ticlopidine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Akedo, Y; Nagakawa, Y; Orimo, H; Yano, H | 1 |
Bando, H; Tsubura, E; Yamashita, T | 1 |
Blum, HE; Huber, M; Ochs, A; Rössle, M; Siegerstetter, V | 1 |
Balducelli, M; Barlera, S; Bernardi, G; Latini, R; Maggioni, AP; Maresta, A; Moccetti, T; Monici Preti, A; Ribeiro da Silva, EE; Sosa, C; Varani, E | 1 |
2 trial(s) available for trapidil and ticlopidine
Article | Year |
---|---|
Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment.
Topics: Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Graft Occlusion, Vascular; Hemodynamics; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; Portal System; Portasystemic Shunt, Transjugular Intrahepatic; Radiography; Ticlopidine; Time Factors; Trapidil; Ultrasonography; Vascular Patency | 1999 |
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Restenosis; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Ischemia; Patient Compliance; Platelet Aggregation Inhibitors; Safety; Stents; Ticlopidine; Trapidil; Treatment Failure; Treatment Outcome | 2005 |
3 other study(ies) available for trapidil and ticlopidine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effect of the combination of antiplatelet agents in man: combination of aspirin, trapidil, ticlopidine and dipyridamole.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; In Vitro Techniques; Platelet Aggregation Inhibitors; Ticlopidine; Trapidil | 1990 |
Effects of antiplatelet agents on pulmonary metastases.
Topics: Adenosine Diphosphate; Animals; Depression, Chemical; Diltiazem; Dipyridamole; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Platelet Aggregation; Thiophenes; Ticlopidine; Trapidil | 1984 |